GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

The doctor recommended getting updated flu vaccines annually to lower the risk of contracting the virus and be protected from ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

Find insight on GSK, Novo Nordisk, tariff escalation and more in the latest Market Talks covering Health Care.

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Dorothy Fink halts reports from health agencies like the CDC, FDA and National Institutes of Health on Tuesday, The H5 bird flu is widespread in wild birds and is causing outbreaks in poultry and ...